ABI-H3733 / BeiGene, Assembly Biosci  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABI-H3733 / Assembly Biosci, BeiGene
NCT05414981: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

Completed
1b
31
Europe, RoW
ABI-H3733, Placebo
Assembly Biosciences
Chronic Hepatitis B
04/23
04/23
NCT04271592: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults

Completed
1
120
RoW
ABI-H3733 Liquid Oral Dosage Form, ABI-H3733 Solid Oral Dosage Form, Placebo to ABI-H3733 Liquid Oral Dosage Form, Placebo to ABI-H3733 Solid Oral Dosage Form
Assembly Biosciences
Chronic Hepatitis B
11/20
01/21

Download Options